Chethan Ramamurthy
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
- Co-authors
- Matthew R. Zibelman (6 shared papers)Elizabeth R. Plimack (4 shared papers)Daniel M. Geynisman (11 shared papers)Elizabeth A. Handorf (6 shared papers)Hossein Borghaei (4 shared papers)Fern Anari (4 shared papers)Daniel P. Petrylak (10 shared papers)Andres Correa (4 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Urologic Oncology Seminars and Original Investigations (7 papers)The Journal of Urology (2 papers)JCO Oncology Practice (1 paper)Medical Decision Making (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Chethan Ramamurthy
48 papers receiving 559 citations
Peers
Comparison fields: 5 of 60
- Oncology 261
- Surgery 201
- Pulmonary and Respiratory Medicine 117
- Immunology 56
- Behavioral Neuroscience 8
Countries citing papers authored by Chethan Ramamurthy
This map shows the geographic impact of Chethan Ramamurthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chethan Ramamurthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chethan Ramamurthy more than expected).
Fields of papers citing papers by Chethan Ramamurthy
This network shows the impact of papers produced by Chethan Ramamurthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chethan Ramamurthy. The network helps show where Chethan Ramamurthy may publish in the future.
Co-authors
The 25 scholars most cited alongside Chethan Ramamurthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 105 | |
| 2 | 2018 | 40 | |
| 3 | 2024 | 37 | |
| 4 | 2019 | 34 | |
| 5 | 2016 | 33 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 30 | |
| 8 | 2022 | 29 | |
| 9 | 2013 | 25 | |
| 10 | 2021 | 23 | |
| 11 | 2023 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2023 | 13 | |
| 14 | 2023 | 12 | |
| 15 | 2024 | 11 | |
| 16 | 2017 | 11 | |
| 17 | 2023 | 10 | |
| 18 | Managing adverse effects of immunotherapy. | 2018 | 9 |
| 19 | 2022 | 7 | |
| 20 | 2023 | 7 |
About Chethan Ramamurthy
Chethan Ramamurthy is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 53 papers that have together received 560 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (27 papers), Cancer Immunotherapy and Biomarkers (19 papers), Urinary and Genital Oncology Studies (7 papers), Prostate Cancer Treatment and Research (6 papers), BRCA gene mutations in cancer (4 papers), CAR-T cell therapy research (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (261 citations), Surgery (201 citations), Pulmonary and Respiratory Medicine (117 citations), Immunology (56 citations) and Behavioral Neuroscience (8 citations). Chethan Ramamurthy has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Matthew R. Zibelman, Elizabeth R. Plimack, Daniel M. Geynisman, Elizabeth A. Handorf, Hossein Borghaei, Fern Anari, Daniel P. Petrylak, Andres Correa, John P. O’Neill and Jessica R. Bauman. Their work appears in journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations, The Journal of Urology, JCO Oncology Practice and Medical Decision Making.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.